Best Patientcentric Podcasts (2024)

1
The 2024 pharma forecast 15:23

3M ago15:23

15:23

Join Isabel and Jade for this special episode of the GOLD podcast as three of last year's guests share their predictions for the pharmaceutical industry in 2024. The panel includes Matt Lewis from Inizio, Rick Hollis from Ipsen and Claudia Martinez from the Access to Medicine Foundation, all of whom share their predictions in their areas of experti…

1
S06 E10: Nurturing the next generation of pharma leaders 21:42

5M ago21:42

21:42

The Season 6 finale of the GOLD podcast has landed! Tune in to hear Isabel and Jade present a discussion with Kinnari Patel, President and Chief Operating Officer, Rocket Pharmaceuticals. In this episode, Kinnari shares her thoughts on how the industry can engage the next generation of scientific leaders to propel itself into the future. Tune in to…

1
S06 E09: A patient's right to thrive, not just survive 25:51

5M ago25:51

25:51

Tune in to the latest episode of the GOLD podcast which sees Isabel sit down for a chat with Wendy Bartie, Senior Vice President and General Manager, US Hematology and Cell Therapy, Bristol Myers Squibb. In the episode, Wendy discusses her passion for developing life-saving cancer drugs with less toxic side effects. Learn about how far the industry…

1
S06 E08: What motivates and challenges GOLD's guests? 11:36

5M ago11:36

11:36

For each episode of Season 6, the GOLD team has asked its podcast guests to reflect on the same question: what gets you up in the morning, and what keeps you up at night? As Season 6 nears its close, Isabel brings you a curated selection of insights from the leaders we have heard from so far. Tune in to find out what motivates these pharma aficiona…

1
Bonus episode: Meet GOLD’s latest catalyst – Roche’s Dr Peter Ahnesorg 8:49

5M ago8:49

8:49

Tune in for a sneak peek of GOLD's latest Catalyst interview with Dr Peter Ahnesorg, Global Hematology Franchise Head, Roche. In this exclusive teaser of the full interview, Peter talks about why he left research for industry, Roche's commitment to ensuring equitable access to its medicines and what he believes are the qualities of a good leader to…

1
S06 E07: A high-speed chase for oncology innovation 17:34

5M ago17:34

17:34

Tune in to the latest episode of the GOLD podcast as Isabel and Jade present a discussion with Jaime Manzanera Gómez, EMEA Brand Director, Oncology, Eisai, who details how oncology teams can best increase the pace of innovation in the field. In this episode, Jaime shares his thoughts on the pace of innovation after the heights of COVID-19, how regu…

1
S06 E06: Changing the tide on health inequities 22:00

6M ago22:00

22:00

Listen in to the newest episode of the GOLD podcast, in which Jade digs deep into the diversity, equity and inclusion (DE&I) space with Marion Brooks, Vice President and US Country Head, Diversity, Equality and Inclusion, Novartis. In the interview, the pair discuss why Marion left a career in commercial for DE&I, the need for more action on health…

1
S06 E05: Why HCPs are losing trust in pharma marketing 14:05

6M ago14:05

14:05

Tune in to a new episode of the GOLD podcast as hosts Isabel and Jade discuss a timely topic for the pharmaceutical industry: how to build trust with healthcare professionals. With a recent survey showing that 80% of HCPs don't trust the content the industry produces for them, the team look at the story behind the statistic. They explore where the …

1
S06 E04: Time to trade in the traditional marketing model? 24:26

6M ago24:26

24:26

Tune in to the latest instalment of the GOLD podcast, which sees Isabel and Jade present a conversation with Rick Hollis, Director of Business Excellence, Ipsen, about his views on how the pharmaceutical industry's customer engagement model needs to grow and evolve. Discover the highs and lows of creating meaningful marketing interactions with this…

1
Bonus episode: Meet GOLD's latest catalyst - ImmunoGen’s Dr Andreas Konieczny 10:00

6M ago10:00

10:00

Tune into to this bonus episode and enjoy an exclusive preview of GOLD’s latest catalyst interview with Dr Andreas Konieczny, Vice President and Head of Medical Affairs Europe, ImmunoGen. In this teaser of the full interview, Isabel and Jade digest Andreas's thoughts on using medical affairs teams to drive drug launches, how to help different perso…

1
S06 E03: Investigating the reality of rare disease research 28:12

6M ago28:12

28:12

Discover the reality behind the expectations of rare disease research and drug development with Isabel and Jade as they present a discussion with Dr Ian Winburn, Vice President, Global Lead for Rare Hematology, Pfizer. Tune in to hear Ian and Isabel discuss the current pharmaceutical landscape for rare diseases, including discussions around clinica…

1
S06 E02: Do happy employees equal better innovation? 27:57

7M ago27:57

27:57

Tune in to the latest episode of the GOLD podcast as Nate Cope, Chief Operating Officer, Otsuka Europe, details how companies can drive innovation by being a great place to work. In this episode, Nate reveals the story behind his passion for prioritising people, what companies should and shouldn't do in their mission to become more people-centric a…

1
S06 E01: Taking the pulse of digital health 35:19

7M ago35:19

35:19

The GOLD podcast is back on the airwaves! Join Isabel and Jade every Tuesday as they speak to a new bunch of inspiring leaders from the pharmaceutical industry. The first interviewee of the season is Parveen Jayia, Therapy Area Head, Breast and Gynaecological Cancers, AstraZeneca, who talks to GOLD about the role digital health can play in the futu…

1
Ep. 43: Running regulatory and clinical operations in an AI world 41:27

8M ago41:27

41:27

Artificially intelligent tools are revolutionizing nearly every stage of the drug discovery process, offering substantial potential to reshape the speed and economics of the industry. As the drug discovery and preclinical stages speed up and potentially produce more drugs to test in the clinical trial phase, how do clinical researchers prepare and …

1
Christy Siegel on striving for disability inclusion 9:20

8M ago9:20

9:20

In this final GOLD Nugget of the series, Jade reflects on her conversation with season finale guest Christy Seigel, General Manager, Breast and Women's Cancers Portfolio, Novartis US Oncology, from her episode ‘Going the extra mile for patients with disabilities’. In this episode, Jade picks out her favourite anecdote Christy shared, which was how …

1
Sarah Jarvis on hitting the mark with medical education 4:22

8M ago4:22

4:22

It is time for the third ‘GOLD nugget’ from Season 5, and Jade is highlighting her favourite insight shared by Sarah Jarvis, Global Lead for the Medical Consulting Practice, ZS, from her episode with colleague Sunil John, ‘Meeting customer needs in medical affairs’. In this clip, Sarah shares findings from ZS's latest Medical Affairs Outlook report…

1
Sunil Verma on balancing the now with the future 6:29

8M ago6:29

6:29

In the second episode of GOLD nuggets, Isabel looks back at her conversation with Dr Sunil Verma, Global Head of Oncology, Medical, AstraZeneca, in which the two discussed the journey to transforming cancer care. In this particular clip, Sunil delves into what motivates him to wake up in the morning and what industry challenge can keep him awake at…

1
Philippe Kirby on the art of collecting customer feedback 5:56

8M ago5:56

5:56

As the GOLD team prepare for the next season of the podcast, take a walk down memory lane with Isabel and Jade as they share their GOLD Nuggets from Season 5. In the first of these special bonus episodes, Isabel looks back at the very first episode of Season 5, featuring Philippe Kirby, Global Head of Channel Engagement and Execution, MSD. Isabel p…

1
Season finale: Going the extra mile for patients with disabilities 27:45

9M ago27:45

27:45

To bring season 5 of the GOLD podcast to a close, join Jade as she sits down with Christy Seigel, General Manager, Breast and Women’s Cancers Portfolio, Novartis US Oncology, to discuss the importance of disability inclusion in the pharmaceutical industry. In this episode, Jade and Christy unpick her transition from general medicine to women’s canc…

1
Ep. 42: Creating drugs at the speed of AI 27:39

9M ago27:39

27:39

Artificial intelligence (AI) is one of the most discussed technologies across all industries. Life science professionals working in the pharmaceutical industry strive to improve people’s lives tackling incredibly complex diseases. Drug development is often perceived as slow. As the pharma industry looks to improve the drug development process AI pr…

1
S05 E09: GOLD Medal Moments 13:36

9M ago13:36

13:36

As Season 5 of the GOLD podcast approaches its end, join Isabel and Jade as they share some of the most memorable moments from the last couple of months. Join our hosts for a trip down memory lane as they look back on their ‘GOLD Medal Moments’ in the penultimate episode of the season. They cover topics such as the importance of avoiding tokenism, …

1
S05 E08: Meeting customer needs in medical affairs 27:30

9M ago27:30

27:30

Uncover the latest customer expectations of medical affairs in this episode of the GOLD podcast, which sees the team speak with not one but two MA leaders from top healthcare consultancy firm, ZS. Join guests Sarah Jarvis, Global Lead for the Medical Consulting Practice, and Sunil John, Principal and Co-Lead Global Medical Affairs Practice, as they…

1
S05 E07: Translating policy into action 13:57

9M ago13:57

13:57

Explore how the pharmaceutical industry can turn diversity, equality and inclusion initiatives into transformational change in the latest episode of the GOLD podcast, where Jade Williams talks to Anita Ralli, Director, Government Affairs, Inclusion and Diversity, Employee Resource Group Lead, Gilead Sciences UK. In this episode, Jade picks the brai…

1
S05 E06: Meet GOLD’s new catalyst – CSL Behring’s Karen Pinachyan 14:35

10M ago14:35

14:35

In this week’s episode, Isabel and Jade share some snippets from the interview with GOLD’s next catalyst Karen Pinachyan, Head of Medical Affairs, Europe, CSL Behring. In this teaser edition of the full interview, Karen shares his motivation for joining the pharmaceutical industry, his thoughts on how to shift the care paradigm towards personalised…

1
S05 E05: Shaping success in cell therapy 19:12

10M ago19:12

19:12

As the US celebrates the 4th of July today, navigate the evolving landscape of cell therapy with hosts Isabel and Jade as they present an insightful discussion with Warner Biddle, Senior Vice President and Global Head of Commercial, Kite, a Gilead Company. Tune in to hear Warner discuss why creating equitable patient access is a ‘team sport’, the p…

1
Ep. 41: CancerX: Reducing incidence, burden, and disparities in cancer care 50:11

10M ago50:11

50:11

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. President Biden has reignited the Cancer Moonshot initiative and set a new national goal: “if we work together, we can cut the death rate from cancer by at least 50% over the next 25 years and improve the experience of people and their families living wit…

1
S05 E04: Pharma, Pride and the LGBTQ+ community 7:20

10M ago7:20

7:20

This week, as we approach the end of Pride Month, the GOLD team looks into how the industry can proactively support patients and staff who are part of the LGBTQ+ community. Join Isabel and Jade as they look at how the industry can avoid 'rainbow washing' and tokenism to drive a positive change both inside and outside their organisations. This will …

1
S05 E03: What will it take to transform cancer care? 27:58

10M ago27:58

27:58

Explore the industry's evolving mission to advance cancer research and care in this new episode of the GOLD podcast with hosts Isabel and Jade, featuring an insightful conversation with Dr Sunil Verma, Global Head of Oncology, Medical, AstraZeneca. In this episode, Isabel uncovers Sunil's passion for working in oncology, his analysis of where cance…

1
S05 E02: Powering the new commercial model 26:49

11M ago26:49

26:49

Tune in to the next episode of the GOLD podcast to hear the team's latest conversation with a leading figure in the pharmaceutical industry. What is being discussed this week? The industry's evolving commercial model. In this week’s episode, Isabel chats with Chetak Buaria, Vice President of Global Commercial Operations, Oncology, Merck Group, abou…

1
S05 E01: Getting to grips with customer experience 33:39

11M ago33:39

33:39

Join Isabel and Jade in kicking off Season 5 of the GOLD podcast with this brand-new episode, which sees the pair return to the airwaves to share more brilliant insights from experts in the pharmaceutical industry. In this first episode, Isabel discusses customer experience with Philippe Kirby, Global Head of Channel Engagement and Execution, MSD. …

1
Ep. 40: CancerX: Breaking down the barriers to digital innovation use in oncology 30:52

11M ago30:52

30:52

The US cancer death rate has fallen by 33% since 1991 with an estimated 3.8 million deaths averted. This is attributed to “good progress” improvements in cancer treatment, decreases in smoking, and increases in early detection. A recent rise in advanced cancer cases reported is believed to be an outcome of the COVID-19 pandemic which delayed screen…

1
Season 4 highlights: GOLD medal moments 17:35

11M ago17:35

17:35

The GOLD team are delighted to announce that Season 5 of The GOLD Podcast is just around the corner. To mark the run up to the next series, Isabel and Jade take a moment in this episode to reminisce about some of the hot topics our brilliant guests shared with us in Season 4. Join our hosts as they journey through their ‘GOLD medal moments’ from la…

1
Ep. 39: Recruiting and retaining experienced principal investigators 39:55

1y ago39:55

39:55

The success or failure of clinical trials is dependent in large part on the engagement of the principal investigator (PI). PIs play an important role in trial selection, site activation, and study execution. This includes but is not limited to, the development and implementation of a strategy to maximize enrollment, optimize data quality, and ensur…

1
Season finale: a sneak peek at the new issue of GOLD 8:38

1y ago8:38

8:38

To mark the final episode of Season 4, Isabel and Jade reminisce about their favourite moments from the series and give an exclusive teaser for the next issue of GOLD – out on 13 April. Expect discussion on topics such as the current state of life sciences innovation in the UK, the latest advances and potential of personalised medicine, a deep dive…

1
S04 E09: Access to oncology treatments, diversity and lessons in leadership 38:54

1y ago38:54

38:54

In the penultimate episode of Season 4, the GOLD team are joined by Dr Zsuzsanna Devecseri, Vice President and Head of Global Oncology Medical, Sanofi Genzyme, to discuss her career journey and experience within the pharmaceutical industry. Isabel and Zsuzsanna explore a wide range of topics during their conversation, including diversity and inclus…

1
Ep. 38: Psychological aspects of clinical trials 32:13

1y ago32:13

32:13

Researchers use controls to help them understand what effect a new therapy or drug might have on a particular condition. Clinical research practice favors placebo controls over usual-care controls. Sometimes a person can have a response, positive or negative, to the placebo control. These responses are known as the "placebo effect and nocebo effect…

1
S04 E08: Beating budget cuts and quick wins for pharma marketers 26:58

1y ago26:58

26:58

This week on the GOLD Podcast, Isabel and Jade present a conversation with Gaurav Sanganee, Managing Director and Principal Consultant, Closing Delta, about how pharmaceutical teams can make the most of a tight budget and leverage digital transformation for the benefit of customers and patients. During their discussion, Jade and Gaurav delve into h…

1
S04 E07: AI, ChatGPT and modernising medical affairs 27:57

1y ago27:57

27:57

This week on the GOLD podcast, Isabel is joined by Matt Lewis, Co-Founder of Inizio Medical Analytics and Innovation, to discuss the future of AI in the pharmaceutical industry and the potential uses of ChatGPT in medical affairs. In this episode, Matt explores the need to modernise medical affairs, top ways pharma teams could save time and resourc…

1
S04 E06: Driving access to all medicines 25:02

1y ago25:02

25:02

This week on the GOLD podcast, the team is joined by Claudia Martínez, Research Programme Manager, Generics and Diabetes Care, Access to Medicine Foundation, to discuss all things access within the pharmaceutical industry. In this episode, Claudia and Jade explore a range of topics, including the story behind her passion for access to medicine, the…

1
S04 E05: International Women's Day special 2023 28:55

1y ago28:55

28:55

This week, the GOLD team is delighted to bring you a special International Women's Day (IWD) podcast featuring Pallavi Bansal, Associate Vice President of Oncology, Genitourinary Cancers and Haematology, Merck, and Emma Chaffin, Vice President, Country Head and Site Lead, Galapagos. The two women reflect on this year's IWD theme, #EmbracingEquity, …

1
Ep. 37: Digital transformation: empowering or encumbering for research sites? 42:46

1y ago42:46

42:46

Clinical research professionals across all types of research organizations often struggled with implementing process improvements and the adoption of digital tools. When external factors (such as pandemic disruptions) force transformational process changes, the adoption of digital tools follows. At that point, the value of the new solutions suddenl…

1
S04 E04: Is medical affairs the Ferrari of the pharma industry? 22:21

1y ago22:21

22:21

This week, Isabel catches up with GOLD’s long-time friend Bora Erdemli, Associate Principal and Leader of Medical Affairs Practice, Europe, ZS. She asks Bora to break down the value of the medical affairs function, asking whether it is being properly utilised by pharma organisations. Bora also shares his thoughts on the future of the MSL, what skil…

1
S04 E03: Super reps, ChatGPT and pharma’s future on social media 23:45

1y ago23:45

23:45

This week, GOLD talks to Darshan Kulkarni, Principal Attorney, The Kulkarni Law Firm, which focuses on regulatory and compliance for life sciences, about key trends in medical affairs and marketing today. He discusses whether MSLs will one day replace sales reps, the role of ChatGPT in healthcare, pharma’s future on social media and much more. If y…

1
S04 E02: Meet GOLD's new catalyst – AZ’s Mina Makar 11:42

1y ago11:42

11:42

This week, the team shares a teaser of GOLD’s latest catalyst interview with Mina Makar, Senior Vice President, Global Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca. He talks to Isabel about why he decided to leave pharmacy for pharma, his passion for tackling unmet needs and championing the patient perspective as well as his thoughts on…

1
S04 E01: New era for neuroscience and the importance of purpose 28:35

1y ago28:35

28:35

The GOLD Podcast is back for Season 4, and it is returning with a bang as Helena speaks to Kavita Panke, Disease Area Strategy Leader, Neurodegeneration, Janssen. An inspiring pharma leader working in a rapidly evolving area of the industry, Kavita reveals the reasons behind her passion for neuroscience, how to build a high-performing team and her …

1
Reshema Kemps-Polanco on clinical trial recruitment 14:53

1y ago14:53

14:53

For our fourth and final GOLD Nugget of Season 3, Helena looks back to our Catalyst interview with Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology, sharing some of Reshema's ideas for tackling clinical trial recruitment gaps, her personal take on Nelson Mandela’s approach to dealing with failure and why she believes e…

1
Ep. 36: Digital predictions for clinical research in 2023 33:31

1+ y ago33:31

33:31

Clinical research can make all the difference when it comes to saving people’s lives or improving their quality of life. In this episode, Mathias Eichler-Mertens, Managing Director of Accenture Life Sciences R&D Europe, and Henry McNamara SVP and GM of Oracle Health Sciences, will discuss what can be done to boost innovation and productivity in the…

1
The 2023 pharma forecast 21:28

1+ y ago21:28

21:28

Join Helena and Isabel in ringing in the new year with a special episode in which five of our previous guests share their predictions for what could lie ahead for the pharmaceutical industry in 2023. Together, they discuss a broad range of topics including greater implementation of digital health, social media’s impact on the space, new legislation…

1
Pav Rishiraj on pharmacovigilance 11:49

1+ y ago11:49

11:49

This GOLD Nugget episode sees Helena reflect on some of the best insights offered by Pav Rishiraj, Director and Head of Pharmacovigilance at Ipsen. She shares some of Pav's thoughts on how the often under-recognised field of pharmacovigilance has changed – particularly its rapid evolution during the COVID-19 pandemic – and its importance as a strat…

1
Paul Simms on pharma’s reputation 8:30

1+ y ago8:30

8:30

In the second of four special bonus episodes, Helena looks back at GOLD’s conversation with Paul Simms, CEO, Impatient Health. She considers some of the gold nuggets that Paul shared, including insights on the current state of pharma’s reputation and the ways in which pharma can recover and bolster its reputation. If you’re interested in learning m…

Podcasts Worth a Listen

Patientcentric Podcasts

Podcasts Worth a Listen

Quick Reference Guide